TFOS DEWS II management and therapy report

L Jones, LE Downie, D Korb, JM Benitez-del-Castillo… - The ocular …, 2017 - Elsevier
The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

Treatment of non-infectious corneal injury: review of diagnostic agents, therapeutic medications, and future targets

DH Dang, KM Riaz, D Karamichos - Drugs, 2022 - Springer
Corneal injuries can occur secondary to traumatic, chemical, inflammatory, metabolic,
autoimmune, and iatrogenic causes. Ocular infection may frequently occur concurrent to …

Dry eye: why artificial tears are not always the answer

M Kim, Y Lee, D Mehra, AL Sabater… - BMJ open …, 2021 - bmjophth.bmj.com
Dry eye disease (DED) is a multifactorial disease that manifests in patients with a variety of
symptoms and signs such as ocular pain, visual issues, rapid tear evaporation and/or …

Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study

JL Alio, AE Rodriguez, R Ferreira-Oliveira… - Ophthalmology and …, 2017 - Springer
Introduction The objective of this study was to evaluate the use of autologous platelet-rich
plasma (PRP) eye drops as monotherapy for the treatment of moderate to severe cases of …

A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America

M Soifer, A Tovar, M Wang, HM Mousa, S Yennam… - The ocular …, 2022 - Elsevier
Purpose To investigate the efficacy and safety of plasma rich in growth factors (PRGF)
eyedrops in the management of patients with ocular surface diseases in North America …

Progress in the use of plasma rich in growth factors in ophthalmology: From ocular surface to ocular fundus

E Anitua, B De la Sen-Corcuera, G Orive… - Expert opinion on …, 2022 - Taylor & Francis
Introduction The use of blood derivatives and especially Plasma rich in growth factors
(PRGF), for regenerative purposes has been a common trend along the last decades in the …

[HTML][HTML] Autologous serum and serum components

A Higuchi - Investigative Ophthalmology & Visual Science, 2018 - tvst.arvojournals.org
Dry eye syndrome is a multifactorial condition on the tear and ocular surface. Autologous
serum eye drop is an effective method for treating dry eye. Autologous serum eye drops are …

Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders

RM Sanchez-Avila, J Merayo-Lloves, AC Riestra… - Medicine, 2018 - journals.lww.com
Plasma rich in growth factors membrane as coadjuvant treatme... : Medicine Plasma rich in
growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders …

Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases

RM Sanchez-Avila, J Merayo-Lloves… - European Journal …, 2020 - journals.sagepub.com
Purpose: To evaluate the efficacy and safety of plasma rich in growth factors eye drops for
the treatment of corneal and ocular surface disorders in patients with graft versus host …

Recovery of corneal innervation after treatment in dry eye disease: A confocal microscopy study

A Barros, J Lozano-Sanroma… - Journal of Clinical …, 2023 - mdpi.com
Purpose: To analyze the changes in corneal innervation by means of in vivo corneal
confocal microscopy (IVCM) in patients diagnosed with Evaporative (EDE) and Aqueous …